Clari Vest Asset Management LLC Sorrento Therapeutics, Inc. Transaction History

Clari Vest Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.24 - $2.33 $14,880 - $27,960	-12,000 Reduced 98.67%	162 $0
Q1 2022 May 04, 2022	SELL	$2.0 - $4.9 $107,004 - $262,159	-53,502 Reduced 81.48%	12,162 $28,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $14,866 - $23,114	-3,197 Reduced 4.64%	65,664 $306,000
Q3 2021 Nov 08, 2021	SELL	$7.41 - $10.99 $17,546 - $26,024	-2,368 Reduced 3.32%	68,861 $526,000
Q2 2021 Aug 09, 2021	SELL	$6.35 - $10.0 $373,602 - $588,350	-58,835 Reduced 45.24%	71,229 $691,000

Q1 2021 May 13, 2021	BUY	$7.03 - $16.51 $62,299 - $146,311	8,862 Added 7.31%	130,064 $1.08 Million
Q4 2020 Feb 09, 2021	SELL	$5.76 - $11.95 $435,185 - $902,858	-75,553 Reduced 38.4%	121,202 $828,000
Q3 2020 Nov 09, 2020	BUY	$6.17 - $18.82 $1.21 Million - $3.7 Million	196,755 New	196,755 $2.19 Million

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.